A hermeneutic phenomenological study of why adults with type 1 diabetes choose to discontinue CSII

European Diabetes Nursing

Volumn 8, Issue 1, 2011, Pages 12-16

  Hayes, M ^a   Frearson, S ^a   Keller, C ^b   Cartmale, A ^c   Lewis Hayes, S ^d  

^a Mile End Hospital   (United Kingdom)

^b BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^d UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

CSII; Discontinuing; Type 1 diabetes

Indexed keywords

EID: 79955015670     PISSN: 15517853     EISSN: 15517861     Source Type: Journal    
DOI: 10.1002/edn.167     Document Type: Article

References (14)

1. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002;25(3):593-8.
2. Bode BW, Tamborlane WV, Davidson PC. Insulin pump therapy in the 21st century: Strategies for successful use in adults, adolescents, and children with diabetes. Postgrad Med 2002;111(5):69-77.
3. Hanas R. Type 1 diabetes in children, adolescents and young adults. How to become an expert on your own diabetes, 3rd edn. London: Class publishing, 2006.
4. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996;19:324-7.
5. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003;26(4):1079-87.
6. Barnard KD, Speight J, Skinner TC. Quality of life and impact of continuous subcutaneous insulin infusion for children and their parents. Pract Diabetes Int 2008; 25(7):278-84.
7. Barnard KD, Skinner, TC. Qualitative study into quality of life issues surrounding insulin pump use in type 1 diabetes. Pract Diabetes Int 2007;24(3)143-8.
8. Ritholz MD, Smaldone A, Lee J, et al. Perceptions of psychosocial factors and the insulin pump. Diabetes Care 2007;30:549-54.
9. Guinn TS, Bailey GJ, Mechlenburg RS. Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy. Diabetes Care 1988;11(1):46-51.
10. Bell D, Ackerson C, Cutter G, et al. Factors associated with discontinuation of continuous subcutaneous insulin infusion. Am J Med Sci 1988;295:23-8.
11. Garmo A, Pettersson-Frank B, Ehrenberg A. Treatment effects and satisfaction in diabetic patients changing from multiple daily insulin injections to CSII. Pract Diabetes Int 2004;21(1):7-12.
12. Karagiahnni P, Sampanis Ch, Katsoulis C, et al. Continuous subcutaneous insulin infusion versus multiple daily injections. Hippokratia 2009;13(2):93-6.
13. Wolf FM, Jacober SJ, Wolf L, et al. Quality of life activities associated with adherence to insulin infusion pump therapy in the treatment of insulin dependent diabetes mellitus. J Clin Epidemiol 1989;42:1129-36.
14. National Institute for Health and Clinical Excellence. Continuous insulin infusion for the treatment of diabetes mellitus. Review of technology appraisal guidance 57. NICE technology appraisal guidance 151. London: NICE, 2008.